CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-18 | Scadden David Director | Exercise or conversion | +2,816 | 20,419 | ||
| 2026-06-18 | Scadden David Director | Exercise or conversion · Restricted stock units | −2,816 | 0 | ||
| 2026-06-18 | Scadden David Director | Grant or award · Restricted stock units | +2,927 | 2,927 | ||
| 2026-06-18 | Scadden David Director | Grant or award · Stock options (right to buy) | +14,950 | 14,950 | ||
| 2025-11-12 | Scadden David Director | Exercise or conversion 10b5-1 | +200 | $18.09 | $4K | 17,803 |
| 2025-11-12 | Scadden David Director | Sale 10b5-1 | −200 | $43.84 | $9K | 17,603 |
| 2025-11-12 | Scadden David Director | Exercise or conversion · Stock options (right to buy) 10b5-1 | −200 | 26,907 | ||
| 2025-10-08 | Scadden David Director | Exercise or conversion 10b5-1 | +200 | $18.09 | $4K | 17,803 |
| 2025-10-08 | Scadden David Director | Sale 10b5-1 | −200 | $41.00 | $8K | 17,603 |
| 2025-10-08 | Scadden David Director | Exercise or conversion · Stock options (right to buy) 10b5-1 | −200 | 27,107 | ||
| 2025-09-30 | Scadden David Director | Exercise or conversion 10b5-1 | +200 | $18.09 | $4K | 17,803 |
| 2025-09-30 | Scadden David Director | Sale 10b5-1 | −200 | $40.00 | $8K | 17,603 |
| 2025-09-30 | Scadden David Director | Exercise or conversion · Stock options (right to buy) 10b5-1 | −200 | 27,307 | ||
| 2025-08-27 | Scadden David Director | Exercise or conversion 10b5-1 | +200 | $18.09 | $4K | 17,803 |
| 2025-08-27 | Scadden David Director | Sale 10b5-1 | −200 | $40.00 | $8K | 17,603 |
| 2025-08-27 | Scadden David Director | Exercise or conversion · Stock options (right to buy) 10b5-1 | −200 | 27,507 | ||
| 2025-07-10 | Scadden David Director | Exercise or conversion 10b5-1 | +1,400 | $18.09 | $25K | 19,003 |
| 2025-07-10 | Scadden David Director | Sale 10b5-1 | −1,400 | $40.00 | $56K | 17,603 |
| 2025-07-10 | Scadden David Director | Exercise or conversion · Stock options (right to buy) 10b5-1 | −1,400 | 27,707 | ||
| 2025-06-20 | Scadden David Director | Exercise or conversion | +2,120 | 17,603 |
Page 1 of 3 · 55 trades